MDxHealth SA (MDXH)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $13.75M
Last updated: Nov 17, 2026 at 11:03 AM ET
MDxHealth SA (MDXH) Competitors
The companies most similar to MDxHealth SA are Precipio (PRPO), bioAffinity Technologies (BIAF) and XWELL (XWEL). By market cap, MDxHealth SA ranks 11th of the 13 companies on this page; GRAIL, LLC (GRAL) is the largest at $5.21B.
Peer Comparison
MDXH's ROIC of -40.5% is below the peer median of -17.6%, and its revenue growth of -17.2% is below the median of -0.8%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| MDxHealth SA (MDXH) | $13.75M | N/A | N/A | -38.3% | -40.5% | -17.2% | 0.00% |
| Precipio Inc (PRPO) | $39.68M | N/A | 1.3x | -4.1% | -5.7% | 8.3% | 0.00% |
| bioAffinity Technologies, Inc. (BIAF) | $4.00M | N/A | 0.3x | -278.9% | -376.1% | -26.0% | 0.00% |
| XWELL Inc. (XWEL) | $5.62M | N/A | 0.2x | -82.9% | N/A | -7.1% | 0.00% |
| CareDx Inc (CDNA) | $4.09B | 48.2x | 6.4x | 25.9% | N/A | 39.3% | 0.00% |
| Castle Biosciences Inc (CSTL) | $1.04B | N/A | 2.7x | -6.1% | -5.4% | 23.9% | 0.00% |
| GRAIL, LLC (GRAL) | $5.21B | N/A | 29.6x | -243.8% | N/A | 3.7% | 0.00% |
| Myriad Genetics Inc (MYGN) | $542.92M | N/A | 0.7x | -16.1% | -29.5% | -1.5% | 0.00% |
| Marker Therapeutics Inc (MRKR) | $14.51M | N/A | 14.5x | -245.5% | N/A | -51.0% | 0.00% |
| Insight Molecular Diagnostics Inc. (IMDX) | $70.03M | N/A | 40.9x | 0.0% | 197.8% | -53.9% | 0.00% |
| TherapeuticsMD Inc (TXMD) | $21.64M | N/A | 5.6x | -6.6% | N/A | -8.7% | 0.00% |
| Exagen Inc (XGN) | $105.37M | N/A | 1.3x | -25.1% | -40.4% | 6.8% | 0.00% |
| Context Therapeutics Inc (CNTX) | $16.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $54.85M | 48.2x | 2.7x | -11.4% | -17.6% | -0.8% | 0.00% |
Similar Companies
These are the 12 companies most similar to MDxHealth SA, ranked by how closely their business, size, sector and industry match. The largest group, 9 of the 12, is in Diagnostics & Research; the other 3 span 2 industries.
| Company | About | Peers |
|---|---|---|
| Precipio Inc (PRPO)Diagnostics & Research | Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. | PRPO competitors |
| bioAffinity Technologies, Inc. (BIAF)Diagnostics & Research | bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. | BIAF competitors |
| XWELL Inc. (XWEL)Diagnostics & Research | XWELL Inc., a health and wellness services company, provides spa services at airports. The company is headquartered in New York, New York. | XWEL competitors |
| CareDx Inc (CDNA)Diagnostics & Research | CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. | CDNA competitors |
| Castle Biosciences Inc (CSTL)Diagnostics & Research | Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests... | CSTL competitors |
| GRAIL, LLC (GRAL)Diagnostics & Research | GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics... | GRAL competitors |
| Myriad Genetics Inc (MYGN)Diagnostics & Research | Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized... | MYGN competitors |
| Marker Therapeutics Inc (MRKR)Biotechnology | Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based... | MRKR competitors |
| Insight Molecular Diagnostics Inc. (IMDX)Diagnostics & Research | OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California. | IMDX competitors |
| TherapeuticsMD Inc (TXMD)Drug Manufacturers - Specialty & Generic | TherapeuticsMD, Inc. is a women's healthcare company in the United States. The company is headquartered in Boca Raton, Florida. | TXMD competitors |
| Exagen Inc (XGN)Diagnostics & Research | Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name... | XGN competitors |
| Context Therapeutics Inc (CNTX)Biotechnology | Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid... | CNTX competitors |
Frequently Asked Questions About MDXH
Who are MDxHealth SA's main competitors?
The companies most similar to MDxHealth SA include Precipio (PRPO), bioAffinity Technologies (BIAF), XWELL (XWEL), CareDx (CDNA) and Castle Biosciences (CSTL), listed from the closest match.
Who is MDxHealth SA's biggest competitor?
GRAIL, LLC (GRAL) is the largest of the similar companies at $5.21B; Precipio (PRPO) is the closest match by business profile, size, sector and industry.
How does MDXH stock compare with its competitors?
MDXH's net margin is -38.3% against a peer median of -11.4%.
Which of MDxHealth SA's competitors pays a higher dividend?
MDxHealth SA pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is MDxHealth SA bigger than its competitors?
No. MDxHealth SA is 11th by market cap among the 13 companies on this page; the largest is GRAIL, LLC (GRAL) at $5.21B.
MDXH pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts